RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS

Ítems similars

• RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
  per: Sushmita Sinha, et al.
  Publicat: (2011-01-01)
• RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
  per: Sushmita Sinha, et al.
  Publicat: (2011-01-01)
• Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG
  per: Sinha, Sushmita, et al.
  Publicat: (2009)
• Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis
  per: Sinha, Sushmita, et al.
  Publicat: (2010)
• Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke
  per: Subramanian, Sandhya, et al.
  Publicat: (2009)